![](http://www.alamy.com/thumbs/6/AB7CE5A2-1CEE-46D1-95E4-8C1074550148/2ACHHAW.jpg)
Treatment for macular degeneration. Syringe being used to inject Lucentis (ranibizumab) into the eye of a patient being treated for age-related macula
Treatment for macular degeneration. Syringe being used to inject Lucentis (ranibizumab) into the eye of a patient being treated for age-related macular degeneration (AMD). Retractors are being used to hold back the eyelids, the eye has been cleaned with iodine eyedrops, and the eye has been numbed with local anaesthetic. Lucentis is a monoclonal antibody that treats the vascular damage to the retina seen in AMD. Lucentis prevents abnormal retinal blood vessels forming, and dries up leaking blood vessels.
Size: 5138px × 3425px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: adult, age-related, amd, antibody, blood, body, caucasian, clinic, close-, condition, degeneration, detail, disorder, doctor, drug, equipment, eye, hospital, human, inject, injecting, lucentis, macular, male, man, medical, medicine, monoclonal, needle, ocular, open, operating, operation, ophthalmic, ophthalmology, patient, people, person, ranibizumab, retina, retinal, retractor, retractors, room, surgeon, surgery, surgical, syringe, treating, treatment, vascular, vessels, white